Evidence map›Paper›PMID 29897329›Full record

ArticleThe Journal of general virology2018

Point-of-care diagnostic assay for the detection of Zika virus using the recombinase polymerase amplification method.

Nadina I Vasileva Wand, Laura C Bonney, Robert J Watson, Victoria Graham, Roger Hewson

Abstract read
In one paragraph

Article in The Journal of general virology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. A need to raise the bar - A systematic review of temporal trends in diagnostics for Japanese encephalitis virus infection, and perspectives for future research.International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases · 2020
    Pooled it
  3. Article
  4. Review
  5. Review
  6. Article
  7. The emergence of oropouche fever: A potential new threat?New microbes and new infections · 2025
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Nadina I Vasileva WandPublic Health England, National Infection Service, Microbiology Services Division, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
Laura C BonneyPublic Health England, National Infection Service, Microbiology Services Division, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
Robert J WatsonPublic Health England, National Infection Service, Microbiology Services Division, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
Victoria GrahamPublic Health England, National Infection Service, Microbiology Services Division, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.
Roger HewsonPublic Health England, National Infection Service, Microbiology Services Division, Porton Down, Salisbury, Wiltshire, SP4 0JG, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The sudden and explosive expansion of Zika virus (ZIKV) from the African continent through Oceania and culminating in the outbreak in South America has highlighted the importance of new rapid point-of-care diagnostic tools for the control and prevention of transmission. ZIKV infection has devastating consequences, such as neurological congenital malformations in infants born to infected mothers and Guillain-Barré syndrome in adults. Additionally, its potential for transmission through vector bites, as well as from person to person through blood transfusions and sexual contact, are important considerations for prompt diagnosis. Recombinase polymerase amplification (RPA), an isothermal method, was developed as an alternative field-applicable assay to PCR. Here we report the development of a novel ZIKV real-time reverse transcriptase RPA (RT-RPA) assay capable of detecting a range of different ZIKV strains from a variety of geographical locations. The ZIKV RT-RPA was shown to be highly sensitive, being capable of detecting as few as five copies of target nucleic acid per reaction, and suitable for use with a battery-operated portable device. The ZIKV RT-RPA demonstrated 100 % specificity and 83 % sensitivity in clinical samples. Furthermore, we determined that the ZIKV RT-RPA is a versatile assay that can be applied to crude samples, such as saliva and serum, and can be used as a vector surveillance tool on crude mosquito homogenates. Therefore, the developed ZIKV RT-RPA is a useful diagnostic tool that can be transferred to a resource-limited location, eliminating the need for a specialized and sophisticated laboratory environment and highly trained staff.

Indexed as

AnimalsConserved SequenceCulicidaeGenetic VariationNucleic Acid Amplification TechniquesPoint-of-Care SystemsReproducibility of ResultsRNA, ViralSensitivity and SpecificityZika VirusRNA, Viralfield-diagnosticisothermalmolecular detectionpoint-of-carerecombinase polymerase amplificationRPAZika

Identifiers

PMID29897329
PMCPMC6171711

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.